Status:
COMPLETED
Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence
Lead Sponsor:
The S.N. Fyodorov Eye Microsurgery State Institution
Conditions:
Neovascular Age-related Macular Degeneration
Eligibility:
All Genders
18-80 years
Brief Summary
The study involves the development of an algorithm for predicting anatomical and functional results of therapy with angiogenesis inhibitors in patients with retinal pigment epithelium detachments in n...
Detailed Description
Patients were divided into 3 groups according to the results of therapy: adhesion of detachment, lack of adherence to detachment, rupture of detachment. For these groups, OCT images of the macular zon...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Linear B - scan through the macular area with the longest detachment
- Other pathologies
- Exclusion criteria:
- Images without detachment
- Images on which it is possible to diagnose the need for therapy only in the presence of additional factors not considered in the study.
Exclusion
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05208931
Start Date
November 1 2021
End Date
September 1 2022
Last Update
April 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The S.N. Fyodorov Eye Microsurgery State Institution
Krasnodar, Russia, 350012